Growth Metrics

BioLineRx (BLRX) Cash from Investing Activities (QoQ) (2013 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 BioLineRx 9.32 Bn 9.30 Bn 154,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -109.18%
Sep 30, 2025 199.16%
Jun 30, 2025 54.70%
Mar 31, 2025 -173.29%
Dec 31, 2024 9.65%
Sep 30, 2024 217.70%
Jun 30, 2024 -151.81%
Mar 31, 2024 181.82%
Dec 31, 2023 -597.80%
Sep 30, 2023 -63.09%
Jun 30, 2023 67.12%
Mar 31, 2023 71.98%
Dec 31, 2022 125.86%
Sep 30, 2022 -248.89%
Jun 30, 2022 98.71%
Mar 31, 2022 26.26%
Dec 31, 2021 9,895.00%
Sep 30, 2021 100.67%
Jun 30, 2021 83.45%
Mar 31, 2021 -524.45%
Dec 31, 2020 13.27%
Sep 30, 2020 234.49%
Jun 30, 2020 -190.58%
Mar 31, 2020 94.01%
Dec 31, 2019 -38.49%
Sep 30, 2019 -16.20%
Jun 30, 2019 166.48%
Mar 31, 2019 -44.57%
Dec 31, 2018 -223.29%
Sep 30, 2018 94.38%
Jun 30, 2018 -66.75%
Mar 31, 2018 124.24%
Dec 31, 2017 202.07%
Sep 30, 2017 79.66%
Jun 30, 2017 -1,370.45%
Mar 31, 2017 -31.06%
Dec 31, 2016 -36.52%
Sep 30, 2016 23.19%
Jun 30, 2016 53.33%
Mar 31, 2016 -46.75%
Dec 31, 2015 472.87%
Sep 30, 2015 -129.78%
Jun 30, 2015 113.53%
Mar 31, 2015 -403.04%
Dec 31, 2014 -2,639.33%
Sep 30, 2014 -104.18%
Jun 30, 2014 118.82%
Mar 31, 2014 -5,008.85%
Dec 31, 2013 -138.34%
Sep 30, 2013 -84.02%
Jun 30, 2013 150.72%